Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
addendum, Aexon, Aknin, Allouch, Allouche, Amyotrophic, Anthony, ASCP, Audrey, automating, Avista, Bachelor, Bassetti, Bern, bid, bioinnovation, biologist, biomanufacturing, bound, breadth, Bundesrat, Calcog, Caligor, career, CARF, CBM, CCPA, Chair, Chairwoman, Claudio, Clawback, Coghlan, compliant, CPA, creditor, CRO, cyber, Dean, degenerative, DEI, delete, diversifying, divestment, Docket, Eastern, Elena, email, endeavor, erosion, Erroneously, escalation, etiology, explain, Faculty, FDAFDA, Florence, fluctuate, Forecast, fundamental, Gallen, GBP, Greenberg, hearing, HEC, hereto, holistic, Huntington, inconsistent, Influential, Inselspital, insourcing, intrusion, ischemic, Israel, Ladle, Lausanne, Lumryz, magazine, mentor, Mercure, Miami, Microsoft, military, multinational, Myrpharm, neuro, Neurocenter, neurophysiology, nightly, online, overdue, Panel, Parkinson, penny, PepKon, Pharmacy, Philly, pinpointing, pioneered, Player, popular, post, professor, prompt, PRSA, Psychopharmacology, QDMTT, ready, refinancing, regain, renowned, rest, Revolutionary, routine, Russia, Schweizerische, shifting, Sorbonne, Southern, SOX, spanning, St, store, stored, stricter, studio, subcontractor, super, switching, tabletop, tech, theft, threat, Titan, Trailblazer, Tribune, unlock, version, viability, Walsh, Wharton, Woman, Women, Young
Removed:
Aalborg, AB, Assistant, biochemistry, built, cap, Catacap, CHEMM, ChemoMetec, computer, Copenhagen, Danish, Diagnostika, Directive, discussing, Econ, Friedrich, ImVisioN, Julier, Kwon, leased, leaving, LLP, Lokke, LUN, Lundbeck, Marcum, MGNX, Miescher, mitigate, MSc, Nextech, noticed, NUE, Nuevolution, observer, Pedersen, Planner, PMG, repay, sensitive, SSI, Stemform, Stig, subordinated, systemic, TAP, Telormedix, TRACON, unexpectedly, unnecessary, unsuccessful, USA, vulnerable
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.1 Description of Securities
- 4.17 Amendment No. 1 to Pre-funded Warrant Dated April 26, 2023 Between NLS Pharmaceutics LTD. and the Pre-funded Warrant Holders Named Therein
- 4.18 License Agreement by and Between NLS Pharmaceutics LTD. and Aexon Labs Inc., Dated March 19, 2024
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 13.2 Certification
- 15.1 Consent of Pricewaterhousecoopers Ag.
- 16.1 Letter of Pricewaterhousecoopers Ag Dated May 15, 2024
- 97.1 Clawback Policy
- Download Excel data file
- View Excel data file
NLSP similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-262489, No. 333-268690 and No. 333-269220) of NLS Pharmaceutics Ltd. of our report dated May 15, 2024 relating to the financial statements, which appears in this Form 20-F.
/s/ PricewaterhouseCoopers AG
Zurich, Switzerland
May 15, 2024
PricewaterhouseCoopers AG, Birchstrasse 160, Postfach, CH-8050 Zurich, Switzerland
Telefon: +41 58 792 44 00, Telefax: +41 58 792 44 10, www.pwc.ch
PricewaterhouseCoopers AG is a member of the global PricewaterhouseCoopers network of firms, each of which is a separate and independent legal entity.